Schering-Plough Corporation announced that the European Commission (EC) has adopted a Decision approving an extension of one therapeutic indication of AERIUS® (desloratadine) for the current European Union (EU) 27 member states as well as Iceland and Norway. The Commission Decision broadened the indications for AERIUS to cover not only “chronic idiopathic urticaria” but “urticaria”, a general term meaning hives. AERIUS now has one of the broadest antihistamine labels in the EU.

This post is an original post by ScienceDaily: Skin Care News

Posted: April 10th, 2008 under skin health.
Comments: none

When a youth suffers from teenage acne, he or she often receives countless suggestions, suggestions about the best way to treat that acne. Yet those who must deal with teenage acne seldom invite such suggestions. What they really need is a ray of hope, assurance that they will not need to go through life with a pimple-filled face.

This post is an original post by ScienceDaily: Skin Care News

Posted: April 10th, 2008 under skin health.
Comments: none

CuraGen Corporation (Nasdaq: CRGN), a clinical-stage biopharmaceutical company focused on oncology, announced that it has advanced CR011-vcMMAE, an antibody-drug conjugate (ADC), into Phase II for the treatment of patients with unresectable Stage III and Stage IV melanoma.

This post is an original post by ScienceDaily: Skin Care News

Posted: April 10th, 2008 under skin health.
Comments: none